Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress
1
Centre for Health Research, Divine Word University, P O Box 483, Madang 555, Madang Province, Papua New Guinea
2
Medical Research Institute, Kunming Pharma, West suburb, Xishan Region, Kunming, China
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2010, 3(12), 3581-3593; https://doi.org/10.3390/ph3123581
Received: 15 November 2010
/
Revised: 8 December 2010
/
Accepted: 9 December 2010
/
Published: 14 December 2010
(This article belongs to the Special Issue New Antimalarial Drugs)
With the rapidly spreading resistance of Plasmodium falciparum to available non-artemisinin antimalarial drugs, new and novel pharmaceuticals are needed. ARCO® is a new generation ACT, one of several artemisinin-based combinations developed in China to counter antimalarial drug resistance. ARCO® is a derivative of two independently developed antimalarials, artemisinin and naphthoquine phosphate, which were combined to form the artemisinin-naphthoquine combination. Both artemisinin and naphthoquine drugs have proven to be efficacious, safe and well tolerated as monotherapies. The artemisinin-naphthoquine combination offers a novel advantage over existing ACTs: it can be administered as a single oral dose (or a 1-day treatment). Several therapeutic studies conducted recently indicate that a single oral dose administration of artemisinin-naphthoquine combination is equally effective and safe as the 3-day treatment with artemether-lumefantrine combination and other existing ACTs. This would make ARCO® the next generation ACT for the treatment of uncomplicated falciparum malaria.
View Full-Text
Keywords:
artemisinin-naphthoquine combination; ARCO; artemisinin; naphthoquine; Plasmodium falciparum
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License
MDPI and ACS Style
Hombhanje, F.W.; Huang, Q. Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress. Pharmaceuticals 2010, 3, 3581-3593. https://doi.org/10.3390/ph3123581
AMA Style
Hombhanje FW, Huang Q. Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress. Pharmaceuticals. 2010; 3(12):3581-3593. https://doi.org/10.3390/ph3123581
Chicago/Turabian StyleHombhanje, Francis W., and Qingyun Huang. 2010. "Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress" Pharmaceuticals 3, no. 12: 3581-3593. https://doi.org/10.3390/ph3123581
Find Other Styles
